Adagio Medical Holdings, Inc.
Data quality: 100%
ADGM
Nasdaq
Manufacturing
Measuring & Analyzing Instruments
$1.41
$0.00
(0.00%)
Mkt Cap: 31.32 M
Price
$1.41
Mkt Cap
31.32 M
Day Range
$1.38 — $1.50
52-Week Range
$0.74 — $2.87
Volume
173,749
Open $1.38
50D / 200D Avg
$1.05
34.58% above
50D / 200D Avg
$1.25
12.65% above
Quick Summary
Key Takeaways
Negative free cash flow of -19.39 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)-100.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-682.19%
Below sector avg (-53.41%)
ROIC-65.46%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio0.84
Interest Coverage-7.53
Valuation
PE (TTM)
-1.25
Above sector avg (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -1.3 | -1.5 |
| P/B | — | 1.6 |
| ROE % | -682.2 | -53.4 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -100.00% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -25.08 M |
| ROE | -682.19% | ROA | -74.41% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -19.39 M |
| ROIC | -65.46% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.84 |
| Interest Coverage | -7.53 | Asset Turnover | 0.00 |
| Working Capital | -1.56 M | Tangible Book Value | -22.25 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1.25 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -61.91% | ||
| Market Cap | 31.32 M | Enterprise Value | 47.83 M |
| Per Share | |||
| EPS (Diluted TTM) | -1.51 | Revenue / Share | 0.00 |
| FCF / Share | -0.87 | OCF / Share | -0.86 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 77.29% |
| SBC-Adj. FCF | -19.98 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | 0.0 | 269,000.0 |
| Net Income | -25.08 M | -53.76 M |
| EPS (Diluted) | -1.51 | -3.70 |
| Gross Profit | — | — |
| Operating Income | -21.89 M | -62.48 M |
| EBITDA | — | — |
| R&D Expenses | 10.64 M | 4.63 M |
| SG&A Expenses | 10.57 M | 6.98 M |
| D&A | 970,000.0 | 740,000.0 |
| Interest Expense | 2.91 M | 1.11 M |
| Income Tax | 0.0 | 0.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Total Assets | 43.25 M | 48.45 M |
| Total Liabilities | 30.85 M | 28.54 M |
| Shareholders' Equity | 12.40 M | 19.91 M |
| Total Debt | 21.04 M | 16.08 M |
| Cash & Equivalents | 17.11 M | 20.59 M |
| Current Assets | 20.08 M | 25.35 M |
| Current Liabilities | 8.23 M | 7.76 M |
{"event":"ticker_viewed","properties":{"ticker":"ADGM","listing_kind":"stock","pathname":"/stocks/adgm","exchange":"Nasdaq","country":"US"}}